Sangamo Biosciences reported $8.59M in Trade Debtors for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Alnylam Pharmaceuticals ALNY:US $ 141.06M 505.52M
Amgen AMGN:US $ 4765M 286M
Avrobio Inc AVRO:US 2.66M 330K
Bayer BAYN:GR 13.05B 2.74B
Biocryst Pharmaceuticals BCRX:US $ 26.21M 1.41M
Biogen BIIB:US $ 2123M 12.8M
Biomarin Pharmaceutical BMRN:US $ 374.94M 49.48M
Bluebird Bio BLUE:US $ 12.66M 12.66M
Gilead Sciences GILD:US $ 4566M 417M
GlaxoSmithKline GSK:LN 8.28B 777M
IONIS PHARMACEUT IONS:US $ 9M 15M
Karyopharm Therapeutics KPTI:US $ 18.75M 865K
Novartis NOVN:VX 8.63B 22M
Omeros OMER:US $ 33.9M 2.06M
Sangamo Biosciences SGMO:US $ 8.59M 0.9M
Sarepta Therapeutics SRPT:US $ 181.56M 33.29M
Ultragenyx Pharmaceutical RARE:US $ 25.38M 0.66M
Vertex Pharmaceuticals VRTX:US $ 1100.37M 171.23M
Ziopharm Oncology ZIOP:US $ 1.51M 6.12M